Riyadh Alshehri at IHOP: A Systematic Review on DOACs Lead-In Therapy in VTE
Riyadh Alshehri, Junior PharmD student at King Saud bin Abdulaziz University for Health Sciences, shared on LinkedIn:
”I was honored to participate in IHOP Conference in its 7th edition by presenting my research titled:
“Evaluation of Direct Oral Anticoagulant Lead-In Therapy Duration on Clinical Outcomes in Venous Thromboembolism: A Systematic Review and Meta-Analysis.”
Presenting this work was a rewarding experience.
It allowed me to share our findings, have meaningful discussions with others in the field, and learn from the diverse research and perspectives presented at the conference.
I would like to express my sincere gratitude to Dr. Abdulmajeed Alshehri for his guidance, mentorship, and continuous support throughout this journey.
Grateful for this valuable experience and looking forward to further academic and research opportunities.”
Stay updated with Hemostasis Today.
-
Aug 14, 2026, 23:18Claire Hills: New Paper on Immune Surveillance and Immune Evasion of Senescent Cells
-
Aug 14, 2026, 23:16Are We Overlooking What Matters Most to Women with Von Willebrand Disease? – RPTH Journal
-
Aug 14, 2026, 23:15Markus Müller: A New Base Editing Approach Targeting PCSK9 to Lower Cholesterol Levels
-
Aug 14, 2026, 23:14Chokri Ben Lamine: Avatrombopag in Hematology – Dosing and Monitoring
-
Aug 14, 2026, 23:13Bianca Rocca: PRECISE-DAPT Score Identifies Bleeding Risk After CABG in Patients With POAF
-
Aug 14, 2026, 19:04Ravi Kumar: Why Lupus Anticoagulant Predicts Clots, Not Bleeding
-
Aug 14, 2026, 18:53Veli Bakalov: The Number Every Hematologist Should Know in Polycythemia Vera
-
Aug 14, 2026, 18:41Marta Velia Antonini: Can Nitric Oxide Protect the ECMO Circuit Without Systemic Anticoagulation?
-
Aug 14, 2026, 18:30Irina Gontschar: What the Epkinly FDA Review Teaches Us About Sponsor Oversight